August 2022 Newsletter
ASBM Representatives Discuss Biosimilars on AI Arthritis Podcast On August 31st, several ASBM representatives joined Tiffany Westrich-Robertson, CEO of the International Foundation for Autoimmune & Autoinflammatory Diseases, to record an episode of the AI Arthritis Voices 360 podcast. The episode discussed examined policy issues surrounding biosimilars and how these affect patients. ASBM was represented in […]